Checkpoint Therapeutics (CKPT) Competitors $4.15 0.00 (0.00%) Closing price 05/16/2025 04:00 PM EasternExtended Trading$4.16 +0.00 (+0.12%) As of 05/16/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CKPT vs. DYN, ETNB, OCUL, AMPH, CALT, WVE, IOVA, SNDX, AUPH, and BGMShould you be buying Checkpoint Therapeutics stock or one of its competitors? The main competitors of Checkpoint Therapeutics include Dyne Therapeutics (DYN), 89bio (ETNB), Ocular Therapeutix (OCUL), Amphastar Pharmaceuticals (AMPH), Calliditas Therapeutics AB (publ) (CALT), Wave Life Sciences (WVE), Iovance Biotherapeutics (IOVA), Syndax Pharmaceuticals (SNDX), Aurinia Pharmaceuticals (AUPH), and Qilian International Holding Group (BGM). These companies are all part of the "pharmaceutical products" industry. Checkpoint Therapeutics vs. Dyne Therapeutics 89bio Ocular Therapeutix Amphastar Pharmaceuticals Calliditas Therapeutics AB (publ) Wave Life Sciences Iovance Biotherapeutics Syndax Pharmaceuticals Aurinia Pharmaceuticals Qilian International Holding Group Checkpoint Therapeutics (NASDAQ:CKPT) and Dyne Therapeutics (NASDAQ:DYN) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, earnings, institutional ownership, profitability, community ranking, valuation and risk. Does the media refer more to CKPT or DYN? In the previous week, Dyne Therapeutics had 13 more articles in the media than Checkpoint Therapeutics. MarketBeat recorded 17 mentions for Dyne Therapeutics and 4 mentions for Checkpoint Therapeutics. Dyne Therapeutics' average media sentiment score of 1.18 beat Checkpoint Therapeutics' score of -0.31 indicating that Dyne Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Checkpoint Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Dyne Therapeutics 13 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders hold more shares of CKPT or DYN? 22.0% of Checkpoint Therapeutics shares are held by institutional investors. Comparatively, 96.7% of Dyne Therapeutics shares are held by institutional investors. 2.1% of Checkpoint Therapeutics shares are held by insiders. Comparatively, 14.1% of Dyne Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has stronger earnings & valuation, CKPT or DYN? Checkpoint Therapeutics has higher revenue and earnings than Dyne Therapeutics. Dyne Therapeutics is trading at a lower price-to-earnings ratio than Checkpoint Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCheckpoint Therapeutics$41K8,478.55-$51.85M-$1.43-2.90Dyne TherapeuticsN/AN/A-$235.94M-$3.59-3.30 Is CKPT or DYN more profitable? Checkpoint Therapeutics' return on equity of 0.00% beat Dyne Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Checkpoint TherapeuticsN/A N/A -659.07% Dyne Therapeutics N/A -57.46%-51.62% Which has more risk & volatility, CKPT or DYN? Checkpoint Therapeutics has a beta of 1.18, meaning that its stock price is 18% more volatile than the S&P 500. Comparatively, Dyne Therapeutics has a beta of 1.19, meaning that its stock price is 19% more volatile than the S&P 500. Do analysts rate CKPT or DYN? Checkpoint Therapeutics presently has a consensus target price of $4.33, suggesting a potential upside of 4.42%. Dyne Therapeutics has a consensus target price of $46.85, suggesting a potential upside of 295.99%. Given Dyne Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Dyne Therapeutics is more favorable than Checkpoint Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Checkpoint Therapeutics 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33Dyne Therapeutics 0 Sell rating(s) 1 Hold rating(s) 12 Buy rating(s) 2 Strong Buy rating(s) 3.07 Does the MarketBeat Community favor CKPT or DYN? Checkpoint Therapeutics received 136 more outperform votes than Dyne Therapeutics when rated by MarketBeat users. However, 77.97% of users gave Dyne Therapeutics an outperform vote while only 67.16% of users gave Checkpoint Therapeutics an outperform vote. CompanyUnderperformOutperformCheckpoint TherapeuticsOutperform Votes18267.16% Underperform Votes8932.84% Dyne TherapeuticsOutperform Votes4677.97% Underperform Votes1322.03% SummaryDyne Therapeutics beats Checkpoint Therapeutics on 11 of the 17 factors compared between the two stocks. Get Checkpoint Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CKPT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CKPT vs. The Competition Export to ExcelMetricCheckpoint TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$347.62M$6.43B$5.35B$8.51BDividend YieldN/A2.66%4.95%4.13%P/E Ratio-2.269.1126.8519.96Price / Sales8,478.55247.13389.69119.17Price / CashN/A65.8538.2534.62Price / Book-8.836.446.764.59Net Income-$51.85M$143.46M$3.23B$248.34M7 Day Performance-0.24%4.42%4.86%5.14%1 Month Performance2.72%7.87%9.88%13.64%1 Year Performance120.74%-5.45%14.64%6.58% Checkpoint Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CKPTCheckpoint Therapeutics1.969 of 5 stars$4.15flat$4.33+4.4%+133.1%$347.62M$41,000.00-2.2610Earnings ReportDYNDyne Therapeutics3.6239 of 5 stars$11.83-0.3%$47.46+301.2%-58.9%$1.34BN/A-3.32100News CoveragePositive NewsETNB89bio3.0198 of 5 stars$8.61-1.4%$27.25+216.5%-13.3%$1.26BN/A-2.9640Positive NewsOCULOcular Therapeutix4.0662 of 5 stars$7.73-12.2%$16.38+111.8%+15.2%$1.23B$63.72M-5.86230Gap DownHigh Trading VolumeAMPHAmphastar Pharmaceuticals4.2047 of 5 stars$25.12+2.5%$43.50+73.2%-41.8%$1.19B$731.97M8.371,620CALTCalliditas Therapeutics AB (publ)N/A$40.00flat$39.25-1.9%N/A$1.19B$1.60B-21.62180WVEWave Life Sciences4.43 of 5 stars$7.73-4.6%$21.17+173.8%+7.3%$1.19B$108.30M-6.96240Analyst RevisionHigh Trading VolumeIOVAIovance Biotherapeutics4.3729 of 5 stars$3.50flat$18.22+420.6%-84.1%$1.17B$164.07M-2.35500Trending NewsAnalyst DowngradeGap DownSNDXSyndax Pharmaceuticals3.9144 of 5 stars$13.57-1.2%$36.20+166.8%-56.7%$1.17B$23.68M-3.74110News CoveragePositive NewsHigh Trading VolumeAUPHAurinia Pharmaceuticals2.4837 of 5 stars$8.26+0.6%$11.50+39.2%+41.9%$1.13B$235.13M-55.06300News CoverageEarnings ReportAnalyst RevisionBGMQilian International Holding GroupN/A$11.20-4.3%N/AN/A$1.09B$25.10M0.00298Gap Down Related Companies and Tools Related Companies Dyne Therapeutics Competitors 89bio Competitors Ocular Therapeutix Competitors Amphastar Pharmaceuticals Competitors Calliditas Therapeutics AB (publ) Competitors Wave Life Sciences Competitors Iovance Biotherapeutics Competitors Syndax Pharmaceuticals Competitors Aurinia Pharmaceuticals Competitors Qilian International Holding Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CKPT) was last updated on 5/17/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredBitcoin Just Broke $100K – Are You Positioned?This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Checkpoint Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Checkpoint Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CKPT Stock Free CKPT Stock Alerts